The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58IPKComputer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis prevention"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis.Cellular Adhesion Promotes Prostate Cancer Cells Escape from DormancyTumour dormancy and clinical implications in breast cancer.Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.Dormancy in solid tumors: implications for prostate cancer.Metastasis review: from bench to bedside.The critical role of bisphosphonates to target bone cancer metastasis: an overview.Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis.Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.Hypoxia and Bone Metastatic Disease.
P2860
Q21195742-351BBC0A-CA01-4BE0-A8F3-73FBD4E44817Q24296295-20C5BD40-D1B7-4297-8921-34AA828C895AQ28474854-DA20F749-79DA-401F-9F0C-67042366AECDQ34122934-A4B9CECB-2622-46A6-AB90-EF36AF684A0BQ34485079-76AF2A80-8D1E-4E36-BC96-9F832D195841Q35185340-BD219F91-62AC-4565-BA73-31B8C67DA8C7Q35668319-B768B7AC-60A2-446D-91AD-70A2BBBFFE0DQ36863179-D8D0B0F6-72C8-4960-9DC5-185ED9E54026Q37432551-2AF74CBD-29AA-4065-B635-7B5D46ED6957Q37456497-804A50D4-1CDB-4CAD-9374-4B0D4C54CA8FQ38101246-820098D7-BF9D-403E-8737-2B2B5DDB9BECQ38237985-EC0BB2DB-226D-4D33-9AE5-24E98B2309B3Q38247428-280B114F-017B-4B96-8046-D6779A76B7ECQ38306308-F25A0F56-9E9C-4BD2-BAFE-32BCEDAB81ABQ38914216-1B11CFCA-C1A8-42B7-B471-196BF0558455Q39361287-323C4E7D-48E4-4EB9-A8B6-87FE9FCBE44A
P2860
The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@ast
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@en
type
label
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@ast
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@en
prefLabel
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@ast
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@en
P2860
P1476
The urokinase receptor (u-PAR) ...... sidual disease in bone marrow?
@en
P2093
Heike Allgayer
Julio A Aguirre-Ghiso
P2860
P304
P356
10.1111/J.1600-0463.2008.00997.X
P577
2008-07-01T00:00:00Z